🧵 GLP-1 receptor agonists (RA) are transforming diabetes and obesity. Women are the predominant users, but uptake has outpaced guidance. 2 papers in @lancetobgyn-wh.bsky.social explore GLP-1RA treatment in women: access, safety, & equity. #EASD2026
tinyurl.com/4h3852em
tinyurl.com
GLP-1 Receptor Agonists in Women's Health
Glucagon-like peptide-1 (GLP-1) receptor agonists are transforming the management of obesity and metabolic disease, with important implications across women’s health.